Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates

Affiliations

• ¹ Northwell Health Cancer Institute and Feinstein Institute of Research, Lake Success, NY.
• ² Xilis Corporation, Durham, NC.
• ³ Stanford Cancer Institute, Stanford, CA.
• ⁴ Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA.
• ⁵ Memorial Sloan Kettering Cancer Center, NY, NY.
• ⁶ Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO.
• ⁷ Mprobe, Inc, Rockville, MD.
• ⁸ Cornell University, School of Medicine, New York, NY.
• ⁹ Department of Medicine, Washington University School of Medicine, St Louis, MO.
• ¹⁰ SEngine Precision Medicine, Seattle, WA.
• ¹¹ Department of Radiology, Stanford University, Stanford, CA.
• ¹² Personalized Healthcare, Genentech, Inc, South San Francisco, CA.
• ¹³ Department of Gynecologic Oncology, University of California at San Francisco, San Francisco, CA.
• ¹⁴ Department of Surgery, Section of Surgical Oncology, Stanford University, Stanford, CA.
• ¹⁵ Division of Hematology Oncology, California Pacific Medical Center, San Francisco, CA.
• ¹⁶ Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA.
• ¹⁷ Department of Radiation Oncology and Northwell Health Cancer Institute, Lake Success, NY.
• ¹⁸ Department of Medicine, Division of Oncology, Washington University School of Medicine in St Louis.
• ¹⁹ xCures Inc, Oakland, CA.
• ²⁰ Independent Clinician, Saratoga, CA.